From genomes to diaries: a 3-year prospective, real-life study of ragweed-specific sublingual immunotherapy.

@article{Molnr2017FromGT,
  title={From genomes to diaries: a 3-year prospective, real-life study of ragweed-specific sublingual immunotherapy.},
  author={V. Attila Moln{\'a}r and Adrienne Nagy and Lilla Tam{\'a}si and Gabriella G{\'a}lffy and Ren{\'a}ta B{\"o}cskei and Andr{\'a}s Bikov and Ibolya Czaller and Zsuzsanna Csoma and Magdolna Krasznai and Csilla Cs{\'a}ki and Gy{\"o}rgyi Zsigmond and Zolt{\'a}n Csontos and Anik{\'o} Kurucz and Edina Kurucz and Be{\'a}ta F{\'a}bos and B{\'a}lint L{\'a}szl{\'o} B{\'a}lint and M{\'a}ria Sasv{\'a}ri-Sz{\'e}kely and Anna Sz{\'e}kely and Eszter Kotyuk and Gergely Tibor Kozma and G{\'a}bor Cserta and Anita Farkas and Zs{\'o}fia G{\'a}l and Andr{\'a}s Gezsi and Andr{\'a}s Millinghoffer and Peter Antal and Csaba Szalai},
  journal={Immunotherapy},
  year={2017},
  volume={9 15},
  pages={
          1279-1294
        }
}
During the last decades, the prevalence of allergy has dramatically increased. Allergen-specific immunotherapy is the only currently available medical intervention that has the potential to affect the natural course of the disease, but there are still many questions and unmet needs hindering its widespread use to fulfill its treatment potential and maximize its benefits for the society. To provide a comprehensive phenome-wide overview in sublingual immunotherapy, using ragweed allergy as a… CONTINUE READING